Literature DB >> 9041658

Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus.

M S Hayney1, G A Poland, P Dimanlig, D J Schaid, R M Jacobson, J J Lipsky.   

Abstract

The transporter associated with antigen processing (TAP) gene products transport peptides from the cytosol to the endoplasmic reticulum for processing by the immune system. We hypothesized that polymorphisms within the TAP genes may influence measles vaccine antigen processing and hence antibody response. TAP genotypes were determined for subjects who were measles vaccine nonresponders (n = 32) and hyper-responders (n = 28). TAP1 and TAP2 alleles were determined by PCR amplification of specific alleles (PASA). Measles vaccine nonresponders were more likely to be homozygous at TAP2 position 665 than were hyper-responders (OR = 5.0, P = 0.016). Lastly, a trend was found in the overall distribution of all TAP2 genotype frequencies between hyper-responders and nonresponders (P = 0.08). No association was found between TAP1 polymorphisms and vaccine response. These data reveal an association between TAP2 genotype and measles vaccine antibody response which may explain one mechanism behind vaccine failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041658     DOI: 10.1016/s0264-410x(96)00133-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.

Authors:  G A Poland
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

2.  Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; Victor J Johnson; Nevin W Wilson; Raymond E Biagini; Wei Wang; Bonnie Frye; David N Weissman; Dori R Germolec; Michael I Luster; Michael M Barmada
Journal:  Vaccine       Date:  2013-09-26       Impact factor: 3.641

3.  Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.

Authors:  R A Kaslow; C Rivers; J Tang; T J Bender; P A Goepfert; R El Habib; K Weinhold; M J Mulligan
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 4.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

5.  B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin.

Authors:  Shikha Malhotra; Susan Kovats; Weiguo Zhang; K Mark Coggeshall
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

Review 6.  Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors.

Authors:  H Van Loveren; J G Van Amsterdam; R J Vandebriel; T G Kimman; H C Rümke; P S Steerenberg; J G Vos
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.